 NEW YORK, and RESEARCH TRIANGLE PARK, N.C., April 28, 2021 GLOBE NEWSWIRE -- Sio Gene Therapies Inc. NASDAQ: SIOX, a clinical-stage company focused on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases, today announced four upcoming oral presentations at the 24th Annual Meeting of the American Society of Gene Cell Therapy ASGCT, to be held virtually between May 11th to May 14th, 2021. 